Seeking Alpha

Corcept Therapeutics beats by $0.01, misses on revenue

  • Corcept Therapeutics (CORT): Q2 EPS of -$0.10 beats by $0.01.
  • Revenue of $1.89M misses by $0.81M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|